Sarcoma / 2019 / Article / Fig 3

Research Article

The Fusion Oncogene FUS-CHOP Drives Sarcomagenesis of High-Grade Spindle Cell Sarcomas in Mice

Figure 3

FUS-CHOP-positive primary tumors. pSECC-sgp53 IVE; Rosa26 FUS-CHOP/+ tumors. (a) Gross images of tumors generated via pSECC-sgp53 in vivo electroporation. (b) Tumor growth over time. (c) Tumor-free survival. (d) H&E: IHC with (e) CHOP antibody and (f) CD31 antibody in tumors generated via pSECC-sgp53 in vivo electroporation. (g) Tissue lineage classification of FUS-CHOP-driven sarcomas and KrasG12D; p53-/-(KP) murine undifferentiated pleomorphic sarcomas by IHC. Negative control tissues: brain (cytokeratin/desmin/vimentin) and liver (S100). Positive control tissues: liver (cytokeratin), muscle (desmin), brain (S100), and kidney (vimentin).
(a)
(b)
(c)
(d)
(e)
(f)
(g)

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.